You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRAF alteration

Showing 1 - 25 of 1,451
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Low-grade Glioma, Advanced Solid Tumor Trial in Worldwide (DAY101)

Recruiting
  • Low-grade Glioma
  • Advanced Solid Tumor
  • San Francisco, California
  • +35 more
May 25, 2022

Solid Tumors, Hematologic Cancers, Metastatic Cancers Trial in Paris (Vemurafenib)

Active, not recruiting
  • Solid Tumors
  • +2 more
  • Paris, France
    Tredaniel
May 18, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United States (Dabrafenib Mesylate, Tazemetostat

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Melanoma
  • Dabrafenib Mesylate
  • +2 more
  • Atlanta, Georgia
  • +6 more
Nov 30, 2022

Malignant Melanoma, Metastatic Melanoma, Immunotherapy Trial (Pembrolizumab, Encorafenib, Binimetinib)

Not yet recruiting
  • Malignant Melanoma
  • +4 more
  • (no location specified)
Mar 31, 2022

Radiomics for prEdiction of lunG cAncer biologY

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • PET/CT
  • Poitiers, France
    CHU Poitiers
Apr 5, 2023

Colorectal Cancer, Resectable Colorectal Carcinoma Trial in Milan (Trastuzumab deruxtecan, Durvalumab, Panitumumab)

Active, not recruiting
  • Colorectal Cancer
  • Resectable Colorectal Carcinoma
  • Trastuzumab deruxtecan
  • +4 more
  • Milan, Lombardia/MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 26, 2023

Solid Tumors Trial in Worldwide (Entrectinib, Alectinib, Atezolizumab)

Recruiting
  • Solid Tumors
  • Daphne, Alabama
  • +156 more
Jan 13, 2023

Metastatic Lung Cancer Trial in France (InvisionFirst® molecular panel)

Active, not recruiting
  • Metastatic Lung Cancer
  • InvisionFirst® molecular panel
  • Bayeux, France
  • +15 more
Aug 22, 2022

A Taiwanese Oncogenetic Panel and Integrated Clinical Data

Recruiting
  • Thyroid Cancer
  • A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients
  • Kaohsiung, Taiwan
  • +7 more
Sep 12, 2022

Low-grade Glioma Trial (Tovorafenib)

Available
  • Low-grade Glioma
  • (no location specified)
Feb 23, 2023

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Soft Tissue Sarcoma Trial in France (drug, combination product, other)

Recruiting
  • Soft Tissue Sarcoma
  • Bordeaux, France
  • +17 more
Oct 4, 2022

Recurrent Melanoma Trial in Columbus (selinexor, Correlative studies)

Active, not recruiting
  • Recurrent Melanoma
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Sep 5, 2022

Cancer Trial (Dabrafenib, Trametinib)

Not yet recruiting
  • Cancer
  • (no location specified)
May 25, 2023

Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)

Recruiting
  • Solid Tumor
  • Haematological Malignancy
  • Belfast, United Kingdom
  • +24 more
Jan 31, 2023

Metastatic Melanoma Trial in San Francisco (Niraparib)

Recruiting
  • Metastatic Melanoma
  • San Francisco, California
    California Pacific Medical Center Research Institute
Oct 15, 2021

Anaplastic Thyroid Cancer Trial in Leiden (dabrafenib/trametinib)

Recruiting
  • Anaplastic Thyroid Cancer
  • Leiden, Zuid-Holland, Netherlands
    Ellen Kapiteijn
Oct 5, 2023

Noninvasive vs. Invasive Lung Evaluation

Completed
  • Non-Small Cell Lung Cancer
  • Guardant360
  • (no location specified)
Apr 29, 2021

Metastatic Melanoma Trial in United States (Placebo for antibiotic, Vancomycin pretreatment, Nivolumab)

Completed
  • Metastatic Melanoma
  • Placebo for antibiotic
  • +4 more
  • Los Angeles, California
  • +6 more
Jun 7, 2022

Non Small Cell Lung Cancer Trial (HLX208+HLX10)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • HLX208+HLX10
  • (no location specified)
Nov 30, 2022

Melanoma Trial in Boston (MCS110, Dabrafenib, Trametinib)

Active, not recruiting
  • Melanoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 14, 2022

Thyroid Gland Anaplastic Carcinoma, Thyroid Gland Squamous Cell Carcinoma Trial in Houston, Salt Lake City (procedure, drug,

Recruiting
  • Thyroid Gland Anaplastic Carcinoma
  • Thyroid Gland Squamous Cell Carcinoma
  • Conventional Surgery
  • +5 more
  • Stanford, California
  • +5 more
Jan 26, 2023

Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV Trial in Chicago

Recruiting
  • Stage IV Colorectal Cancer Positive for BRAF V600E Mutation
  • +2 more
  • Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab
  • Chicago, Illinois
    Northwestern University
Nov 16, 2022

Advanced Colorectal Cancer Trial in Hangzhou (Cetuximab Dabrafenib Tislelizumab)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Cetuximab Dabrafenib Tislelizumab
  • Hangzhou, Zhejing, China
    Zhejiang Cancer Institute & Hospital
Jul 19, 2023

Colorectal Cancer, BRAF V600E Mutation Positive Trial (Encorafenib Oral Capsule + Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • BRAF V600E Mutation Positive
  • Encorafenib Oral Capsule + Cetuximab
  • (no location specified)
Jan 30, 2023